What are the specific translational challenges preventing IR agonist therapies from reaching clinical practice?

OPEN

The abstract mentions 'translational challenges that must be addressed' but doesn't specify what these barriers are. Understanding these obstacles is critical for advancing promising preclinical therapies to patients with autoimmune diseases. Gap type: open_question Source paper: Inhibitory receptor agonists: Emerging strategies in immune modulation. (2026, J Exp Med, PMID:41915422)

Priority: 0.64 Domain: immunotherapy Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: What are the specific translational challenges preventing IR agonist therapies from reaching clinical practice? is a 0.64 priority gap in immunotherapy. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the specific translational challenges preventing IR agonist therapies from reaching clinical practice? — INVOKE-2 (completed)

📈 Living Dashboards

0

Hypotheses

0.000

Top Score

0.000

Avg Score

0

Debates

0.00

Avg Quality

0%

Resolution

0

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (15)

IR→neuroinflammationIR→NLRP3IR→TNFIR→strokeBACE1→IR

▸ Show 10 more

IR→METCERS2→IRANGPT1→IRHDAC3→IRIR→JNKH2AX→IRAMPK→IRIR→diabetesHIF→IRIR→PINK

associated with (9)

CLCN1→IRCP→IRALOX12→IRIR→neuroinflammationHDAC3→IR

▸ Show 4 more

H2AX→IRIR→Alzheimer's diseaseIR→diabetesIR→LDL

biomarker for (1)

data in (2)

benchmark_ot_ad_answer_key:IR→IRIR→benchmark_ot_ad_answer_key:IR

expressed in (2)

IR→macrophagesIR→TH

inhibits (8)

DNA→IRIR→TGM2HDAC3→IRIR→neurodegenerationATM→IR

▸ Show 3 more

IR→NBS1IR→PARP1IR→RAD51

interacts with (3)

IR→MAP2IR→neurodegenerationIR→neuroinflammation

participates in (4)

IR→ferroptosisIR→oxidative stress responseIR→PI3K-AKT-mTOR signalingIR→synaptic plasticity

protects against (2)

HDAC3→IRIR→diabetes

regulates (2)

IR→PSEN1IR→LRP2

targets (2)

IR→LRP2metformin→IR

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps